Franceville, Gabon — July 15, 2026 In a pivotal effort to bolster public health and safety, the Agence nationale du médicament et des autres produits de santé (ANMAPS) of Gabon has launched the national campaign ‘Signale! ‘in Franceville. This initiative is aimed at fostering a culture of vigilance among patients and healthcare professionals regarding adverse drug reactions.
The ‘Signale! ‘campaign, which is part of a wider national pharmacovigilance strategy, has been accelerated in the wake of the COVID-19 pandemic. It follows a successful deployment in Libreville and the provincial capitals, with the campaign emphasizing the importance of reporting any adverse effects to the medication hotline 1421.
During the launch, representatives from epidemiological surveillance and staff from both public and private health facilities received training and awareness sessions.
The primary goal is to encourage the systematic reporting of adverse effects to enhance patient safety.
The campaign’s emphasis on medication safety comes as a critical step towards a more inclusive and efficient national pharmacovigilance system. It represents a new phase in the government’s efforts to ensure that the healthcare landscape in Gabon is robust and responsive to the needs of its population. KICKER: As the ‘Signale!
‘campaign gains traction in Franceville, the government’s multifaceted approach to health, education, and digital transformation signals a hopeful trajectory for Gabon’s future.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Agpgabon
Source: Redaction
